Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

T.GCSC
Sort by: Date|Relevance

Software For Safe Medical Cannabis Access

Alternate Health’s integrated health services features clinical laboratories and CanaPass - online patient management software for safe access to medical cannabis. Currently generating revenue, Alternate Health plans to reinvest profit...
BTV-Business Television | June 9, 2018 |

Coronavirus Strikes Back. But Force Is Strong With Gold

We all fear the second wave of infections. But the U.S. hasn’t even controlled the first one! Bad news for Americans, but good news for gold. Please take a look at the chart below. As you can see, the epidemiological situation in the United States d...
Arkadiusz Sieron | June 30, 2020 |

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...
Dave Jackson | June 16, 2021 |

Silver Dips Lower but Remains Close to 17.00 Level

Silver prices have dropped slightly, as the metal trades around $16.90. The dramatic vote to impeach President Trump did not stir silver, which continues to trade close to the symbolic $17 level. Kenny Fisher Silver has recorded los...
FX Empire | December 19, 2019 |

Silver Demand vs Gold Demand

I recently talked with Jim Goddard at HoweStreet radio about gold, silver, miners, the dollar, among other things. Many markets are at major turning points and its critical that investors understand where we are in the major market cycles. Just think of this for a minu...
Chris Vermeulen | April 29, 2020 |

Rare Diseases Biotech Provides Opportunity

A ROTH Capital Partners report discussed why the stock price is at its current level and noted upcoming catalysts for the company. In a March 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi indicated that the recent drop in Soleno Therapeutics Inc.'s (SL...
Streetwise Reports | March 22, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...
Streetwise Reports | April 16, 2020 |

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) presented two posters o...
Streetwise Reports | August 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...